These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 33957088

  • 1. Comparative assessment of interventions for treating cutaneous leishmaniasis: A network meta-analysis of randomized clinical trials.
    Sridharan K, Sivaramakrishnan G.
    Acta Trop; 2021 Aug; 220():105944. PubMed ID: 33957088
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
    Asilian A, Sadeghinia A, Faghihi G, Momeni A, Amini Harandi A.
    Ann Trop Med Parasitol; 2003 Jul; 97(5):493-8. PubMed ID: 12930612
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
    Brito NC, Rabello A, Cota GF.
    PLoS One; 2017 Jul; 12(9):e0184777. PubMed ID: 28926630
    [Abstract] [Full Text] [Related]

  • 4. [Management of cutaneous leishmaniasis in adults and children].
    Minodier P, Noël G, Blanc P, Uters M, Retornaz K, Garnier JM.
    Med Trop (Mars); 2005 Nov; 65(5):487-95. PubMed ID: 16465821
    [Abstract] [Full Text] [Related]

  • 5. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis.
    Rashid HU, Ullah I, Adeeb H, Zeb M, Mohammad A, Rehman N.
    J Ayub Med Coll Abbottabad; 2020 Nov; 32(4):558-561. PubMed ID: 33225663
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis.
    Solomon M, Ollech A, Pavlotsky F, Barzilai A, Schwartz E, Baum S, Astman N.
    Acta Derm Venereol; 2024 Apr 29; 104():adv35089. PubMed ID: 38682801
    [Abstract] [Full Text] [Related]

  • 7. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
    El-Sayed M, Anwar AE.
    J Eur Acad Dermatol Venereol; 2010 Mar 29; 24(3):335-40. PubMed ID: 19744259
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fractional Ablative CO2 Laser Followed by Topical Application of Sodium Stibogluconate for Treatment of Active Cutaneous Leishmaniasis: A Randomized Controlled Trial.
    Artzi O, Sprecher E, Koren A, Mehrabi JN, Katz O, Hilerowich Y.
    Acta Derm Venereol; 2019 Jan 01; 99(1):53-57. PubMed ID: 30281141
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.
    Faghihi G, Tavakoli-kia R.
    Clin Exp Dermatol; 2003 Jan 01; 28(1):13-6. PubMed ID: 12558620
    [Abstract] [Full Text] [Related]

  • 13. Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.
    Yesilova Y, Surucu HA, Ardic N, Aksoy M, Yesilova A, Oghumu S, Satoskar AR.
    J Dermatolog Treat; 2016 Jan 01; 27(1):83-7. PubMed ID: 26105204
    [Abstract] [Full Text] [Related]

  • 14. Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran.
    Khamesipour A, Mohammadi A, Jaafari M, Eskandari S, Tasbihi M, Javadi A, Afshari F, Mortazavi H, Firooz A.
    East Mediterr Health J; 2022 Sep 29; 28(9):658-663. PubMed ID: 36205204
    [Abstract] [Full Text] [Related]

  • 15. Fractional ablative carbon dioxide laser followed by topical sodium stibogluconate application: A treatment option for pediatric cutaneous leishmaniasis.
    Hilerowicz Y, Koren A, Mashiah J, Katz O, Sprecher E, Artzi O.
    Pediatr Dermatol; 2018 May 29; 35(3):366-369. PubMed ID: 29574997
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
    Asilian A, Sadeghinia A, Faghihi G, Momeni A.
    Int J Dermatol; 2004 Apr 29; 43(4):281-3. PubMed ID: 15090013
    [Abstract] [Full Text] [Related]

  • 17. Leishmania tropica in children: a retrospective study.
    Solomon M, Schwartz E, Pavlotsky F, Sakka N, Barzilai A, Greenberger S.
    J Am Acad Dermatol; 2014 Aug 29; 71(2):271-7. PubMed ID: 24775403
    [Abstract] [Full Text] [Related]

  • 18. A Case Series of 36 Patients Treated for Old World Cutaneous leishmaniasis.
    Saffarian Z, Marandi ZV, Shakoei S, Hamzelou S, Rafati S.
    J Clin Aesthet Dermatol; 2024 Jul 29; 17(7):38-42. PubMed ID: 39006810
    [Abstract] [Full Text] [Related]

  • 19. [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].
    Saldanha AC, Romero GA, Merchan-Hamann E, Magalhães AV, Macedo Vde O.
    Rev Soc Bras Med Trop; 1999 Jul 29; 32(4):383-7. PubMed ID: 10495667
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.